^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Promitil (pegylated liposomal mitomycin-c prodrug)
i
Other names: LPMX-1, PL-MLP, LPMX1, PLMLP, LPMX 1, PL MLP
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
LipoMedix
Drug class:
DNA synthesis inhibitor, Alkylating agent
Related drugs:
7ms
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy (clinicaltrials.gov)
P2, N=20, Active, not recruiting, Lipomedix Pharmaceuticals Inc. | Recruiting --> Active, not recruiting
Enrollment closed
|
BRCA (Breast cancer early onset)
|
Promitil (pegylated liposomal mitomycin-c prodrug)
over1year
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy (clinicaltrials.gov)
P2, N=20, Recruiting, Lipomedix Pharmaceuticals Inc.
New P2 trial
|
BRCA (Breast cancer early onset)
|
Promitil (pegylated liposomal mitomycin-c prodrug)
Share via
